The Continuation Vehicle Boom: When GPs Cannot Sell, They Roll

Five years ago, a continuation vehicle was a niche maneuver reserved for trophy assets or legacy portfolios that had overstayed their fund life. In 2026, it is a mainstream liquidity tool. Nearly three quarters of the largest private equity firms have closed at least one continuation transaction, and the 2026 Global Private Equity Outlook shows 46 percent of respondents actively using GP-led secondaries or CVs to return capital to limited partners, almost double the share from last year. The boom is telling business owners something important about how their sponsors are actually thinking.

What a continuation vehicle actually is

A continuation vehicle, usually called a CV, is a new fund set up by a private equity sponsor to buy one or more companies out of an older fund the sponsor already manages. Existing limited partners can either cash out at a negotiated valuation or roll their position into the new vehicle alongside new secondary buyers. The sponsor keeps managing the asset, the LPs who want liquidity get it, and the asset stays under the same operational roof with a fresh holding period and a new set of incentives.

The mechanics matter because CVs are not exits in the conventional sense. Nothing gets sold to a third-party strategic or to another sponsor. The business, its management team, and its day-to-day reality usually stay exactly where they were. What changes is the ownership cap table, the valuation mark, and the exit clock.

Why the market exploded

The surge is about arithmetic, not fashion. Private equity entered 2025 with roughly 31,000 unsold portfolio companies, a median holding period pushing six years (well past the traditional four to five year window), and limited partners actively demanding distributions. The IPO lane was inconsistent, strategic buyers were selective, and sponsor-to-sponsor sales were crowded. Something had to give.

GP-led transaction volume hit $115 billion in 2025, with continuation vehicles accounting for 89 percent of that activity. Single-asset CVs, which concentrate an entire new fund around one portfolio company, have grown at roughly 48 percent compound since 2019. The GP-led secondary market has effectively become a parallel exit channel sitting alongside strategic sales, sponsor sales, and IPOs.

What it means if your business is inside one

If your company is held by a PE sponsor and the fund is in its sixth or seventh year, a CV conversation is a realistic possibility. There are three things worth understanding before it arrives.

First, a CV is not a vote of no confidence. Historically, continuation vehicles were used for underperformers and legacy positions, which is why they carried a stigma. That has changed. Sponsors now use single-asset CVs specifically for their best-performing assets, the ones they want more time with. If your company is being rolled into a CV, it usually means the sponsor sees meaningful upside and does not want to hand it off to a competitor.

Second, the valuation has to be tested. CVs sit under intense scrutiny from LP advisory committees and increasingly from regulators. The SEC's private fund rules and investor expectations now require some form of external market check on pricing, which in practice means running a limited sale process to establish that the CV valuation is fair. As a management team, that means you may be pulled into diligence meetings with third-party bidders even if the intended destination is the continuation vehicle.

Third, your own equity and incentive plan gets reset. Management rollover into a CV typically involves renegotiated equity, updated vesting, and sometimes a new grant tied to the fresh hold period. The economic terms inside a CV can be better than a traditional exit if the sponsor sees upside, but they are almost never a simple extension of what you already had. Treat the conversation the way you would treat a sale, because that is how it functions for everyone on the cap table.

The risks that are now visible

The boom is new enough that the courts are still catching up. Private Equity Litigation trackers flagged GP-led secondary disputes as a rising risk category in April 2026, focused on conflicts-of-interest claims from LPs who felt the CV valuation was too low. The structural issue is that the sponsor sits on both sides of the transaction, negotiating a sale price with itself, and even with independent advisors and LPAC approval, the optics can be awkward when the asset subsequently performs well.

For the company caught inside a contested CV, the fallout can include deposition requests, management time pulled into discovery, and delayed operational decisions. None of that is fatal, but owners and CEOs should understand that a CV is a more complicated liquidity event than a sale, not a simpler one.

What to watch next

Three signals will tell you whether the CV boom plateaus or keeps expanding. First, watch LP sentiment. LPs currently tolerate roughly one continuation vehicle per year per sponsor, and any tightening of that informal cap would slow the market. Second, watch regulatory posture. The SEC's private fund rules and state-level investor advocates are paying close attention to pricing integrity, and enforcement actions would reshape how CVs are structured. Third, watch the traditional exit lanes. If the IPO market genuinely reopens and sponsor-to-sponsor activity stays strong, the pressure that created the CV boom eases, and the market may normalize around a smaller steady-state volume.